How Quick Should Corporate General Counsel Be to Use Litigation Finance?
IMN hosted its 6th annual Financing, Structuring and Investing in Litigation Finance conference in New York City yesterday. The event was well-attended and featured a diverse array of stakeholders, including funders, law firms, investors and corporate counsel. One of the panels covered the topic of General Counsel and their mindsets, attitudes and approach to adopting litigation funding.
The panel was moderated by Martin Gusy (MG), Partner at Bracewell. Panelists included Edward Reilly (ER), Managing Member at McDonald Hopkins, Vincent Montalto (VM), Partner at DLA Piper, and William Derrough (WD), Managing Director at Moelis & Company.
The discussion covered the following topics:
- When and how should corporate general counsel utilize litigation finance?
- Can litigation finance replace corporate legal budgets? Should it?
- How attractive is the monetization of solid cases and arbitration? Is the factoring of legal fees a bad habit to start?
- What are issues large corporations face when using litigation finance? Are there reputational issues? Others?
- Will more disclosure in the market make the use of litigation finance more attractive and viable for public companies?
- How active are corporates in monetizing large claims?
Below are some key takeaways from the discussion:
MG: Is the GC office looked at as being a profit center, or cost center? Can you make that shift (from cost to profit)? The benefits can take years to realize, so it’s a challenge to get the GC to think about making an investment for a payout 5 or 6 years down the road.
VM: GCs do not have the mindset of affirmative recovery. It takes a shift in mindset for in-house counsel to start thinking about pursuing affirmative recovery. There are too many other important things to do, and limited resources. Funders need to get some wins, and show them it works. When a portion of the settlement or award goes back to the GC office, then they will begin to shift their mindset towards being more of a profit center.
ER: There is a corporate mindset in the GC office—they are risk averse. A GC’s job is to avoid all kinds of risk. It takes a lot to get a GC to think outside the box. If you look at the Buford surveys, finance guys always have an interest in litigation funding, until they look at cost of capital and think ‘I can do better than that.’ They don’t want to take the risk on the case, and even if they win, pay off a huge percentage. So it will take a lot to change their mindsets.
WD: We've been working on a case for 7-8 years. The CFO or CEO can easily decide to stop spending money on this at any time. So duration risk is a real risk. That said, we think it almost always makes sense, even with higher cost of capital. Take any WACC, and it is almost always recourse. Litigation funding is non-recourse. So that is a great selling point tot he CFO.
Also, the number of players out there has probably doubled in last 5 or 6 years, so when we run a process, we can get interesting participation, not cookie cutter proposals. Some want to be in New York state court, some don’t. Different jurisdictions are favored. So you can find the funder that works best for you.
And remember, the perception of an asset class can change over time. There was a time when asset-based financing was a dirty word. Nobody at the bank did any loan-to-value work. If you needed extra money, you went to asset-based lenders. All of those funders have been bought out by banks. Now ABS is a massive market. We have to get past people’s natural responses… showing people IRR, examples of successful litigation. This will help change minds.
MG: Disclosure is a topic we should consider. By show of hands: How many of you have dealt with cases where you had to disclose the identity of a funder?
(very few hands are raised).
How many of you had to disclose the entirety of a funding agreement?
(a few more hands, but not many).
VM: There are some GCs who would take offense if a funder takes an adverse position to them in a case. If they find out funder X is funding a case against them, they might write off that funder forever. I’ve had that happen to clients. This brings up part of the risk of disclosure, for funders. There is still an emotional response from GCs around this.
If the industry spoke in one voice, that would be a lot easier for corporates. Some funders are in favor of disclosure of a funding agreement. Others say absolutely no disclosure, period. We can all agree, disclosure of a funding agreement In its entirety has work product and other issues—everyone in the industry should agree on that. So that can be a starting point. The industry needs to speak in one voice on this, so GCs can better wrap their heads around the issue.